A. J. KazimiChief Executive OfficerChief Executive Officer
Mr. Kazimi founded Cumberland Pharmaceuticals in 1999 and has served as Chief Executive Officer and Chairman of the Board of Directors since its inception. Prior to forming Cumberland, he served as President and Chief Operating Officer of Therapeutic Antibodies Inc., a biopharmaceutical company. During his 11 years with the company, Mr. Kazimi oversaw operations in three countries and played a key role in the company’s product development strategies, licensing and distribution agreements, and the raising of more than $100 million through equity and debt financings, as well as its initial public offering. Earlier in his career, he worked at Brown-Forman Corporation, rising through a series of management positions. Mr. Kazimi currently serves on the board of directors for the Nashville Health Care Council, an industry association representing the largest concentration of healthcare companies in the United States and has served on the board for Aegis Toxicology Sciences Corporation, a federally certified forensic toxicology laboratory. He also serves as Chairman and Chief Executive Officer of Cumberland Emerging Technologies, Inc. (CET). He holds a B.S. from the University of Notre Dame and an M.B.A. from the Vanderbilt Owen Graduate School of Management.
Martin E. CearnalExecutive Vice President & Chief Commercial OfficerExecutive Vice President & Chief Commercial Officer
Prior to joining Cumberland as Senior Vice President of Commercial Development in 2008, Mr. Cearnal served as President and Chief Executive Officer of Physicians World. During his 15-year tenure, the company became the largest provider of continuing medical education before its acquisition by Thomson Healthcare in 2000. He served as President of Thomson Physicians World from 2000 to 2003 and Executive Vice President-Chief Strategy Officer for Thomson Medical Education from 2003 through 2005. During his more than 49 years in the healthcare industry, Mr. Cearnal has been involved with the launches of such noteworthy pharmaceutical products as Lipitor®, Actos®, Intron-A®, Straterra®, Botox®, and Humira®. He spent 17 years at Revlon Healthcare in a variety of domestic and international pharmaceutical marketing roles, culminating in his position as Vice President, Marketing for International Operations. Mr. Cearnal has also served on Cumberland’s Board of Directors since 2004. He is a graduate of Southeast Missouri State University.
Leo Pavliv, R.Ph.Executive Vice President, Operations & Chief Development OfficerExecutive Vice President, Operations & Chief Development Officer
Leo Pavliv is Chief Development and Operations Officer at Cumberland Pharmaceuticals and has over 30 years of experience in developing pharmaceutical and biologic products. His job responsibilities include directing overall drug development activities including clinical and non-clinical development, regulatory affairs, product development, manufacturing, supply chain, and quality affairs. In addition, Leo is responsible for varied aspects of business development, including evaluating and selecting product candidates. He has experience in developing a wide variety of drugs, including recombinant and natural proteins, MAb’s, peptides, small molecules, oligonucleotides, and devices in parenteral, oral, inhaled, and topical dosage forms. Leo has been involved in bringing well over 50 products from concept to clinical trials with more than 10 new or supplemental approvals. He has numerous patents, has written several book chapters, a number of articles, and has made numerous professional presentations.
James L. HermanSenior Vice President, National Accounts & Chief Compliance OfficerSenior Vice President, National Accounts & Chief Compliance Officer
As Senior Vice President of National Accounts, Mr. Herman handles all national sales, including wholesalers and retail chain buying offices, managed care home offices and federal government accounts. He also oversees corporate compliance efforts. Previously, he was with Solvay Pharmaceuticals where he served as Director of Managed Care, as well as Director of Trade Affairs and Customer Service. Earlier in his career, Mr. Herman spent eight years with Schwarz Pharma, where he held national sales leadership positions. He holds a B.S. from Indiana University and an M.B.A. from Cardinal Stritch University.
Todd AnthonyExecutive Director, Organizational DevelopmentExecutive Director, Organizational DevelopmentMr. Anthony joined our company in 2010 and is Executive Director, Organizational
Development. He is responsible for all training activities related to product knowledge and
selling skills for our Sales Organization, as well as sales management, corporate training, and
leadership development. He began his pharmaceutical career with Berlex Laboratories Inc. in
1991 and spent 19 years at that company which is now Bayer HealthCare Pharmaceuticals
following the 2006 acquisition of Schering AG. While there he held positions of increasing
responsibility including roles in Sales, Sales Training, Sales Management and Corporate
Management/Leadership development. He has a BSN degree from D’Youville College in Buffalo,
Michael BonnerChief Financial Officer, Senior Director Finance & AccountingChief Financial Officer, Senior Director Finance & Accounting
Mr. Bonner has more than 16 years of experience in financial management, accounting and reporting, primarily within the health care industry. Prior to joining Cumberland, Mr. Bonner worked for over six years with Advocat Inc., a $300 million NASDAQ listed skilled nursing services provider, as Vice President of Accounting and Financial Reporting. Prior to that, Mr. Bonner served in a financial reporting role at LifePoint Hospitals Inc., a NASDAQ listed acute care hospital company. He started his career at Ernst & Young where he spent close to five years in their assurance practice. A Certified Public Accountant, Mr. Bonner holds both a Bachelor of Science in Accounting and a Masters of Business Administration.
Tan Cheow ChoonSenior Director, International BusinessSenior Director, International Business
Mr. Tan is the Senior Director of International Business Development for Cumberland Pharmaceuticals. His responsibilities include identifying new partnership opportunities and managing those relationships in the Asian market. Prior to joining Cumberland, he was Vice President of Southeast Asia & Korea at Hospira Inc. His career also includes roles in banking & finance with the United Overseas Bank, Singapore as well as the establishment, development & management of pharmaceutical partnerships across Asia as General Manager, Asia for Mayne & Faulding Pharmaceutical of Australia. Mr. Tan is an Accountant, earning his Bachelor of Accountancy from the National University of Singapore and an MBA from Monash University in Australia.
Barry L. LeeSenior Director, Hospital ProductsSenior Director, Hospital Products
In his role as Senior Director, Hospital Products, Mr. Lee is responsible for all marketing activities associated with the commercialization of Caldolor®, the company’s intravenous formulation of ibuprofen. Prior to joining the company in 2008, he spent 24 years with Bayer Healthcare Pharmaceuticals, Inc. There he held a variety of pharmaceutical sales and marketing positions and, most notably, was responsible for the launch of Yasmin® in 2001—one of the most successful industry product launches at that time. He earned a B.S. degree from Texas A&M University.
Cindy PattonSenior Director, Field MarketingSenior Director, Field Marketing
Ms. Patton began her industry career as a Ciba Geigy sales representative in 1983. Relocating to the Ciba Geigy corporate office in 1991, she served in the Customer Marketing Group, becoming the Director of Institutional Marketing in 1995. Following the merger that created Novartis, she held positions which included Lotensin Product Director and Ciba Novartis Sales Director for the New York Region. She graduated magna cum laude from Lambuth College with a B.B.A.
Adam MostafaManaging DirectorManaging Director
In his role as a Managing Director, Mr. Mostafa is responsible for managing our investment banking activities and supporting our institutional investor interactions. Adam is an experienced biopharmaceutical investment banker who has worked for over 17 years in corporate finance. Prior to joining Cumberland in 2017, Mr. Mostafa worked on Wall Street at Cantor Fitzgerald & Co. as Managing Director, Healthcare Investment Banking. There, he was involved predominantly in financing life sciences companies in the specialty pharmaceutical and biotechnology sectors. He also served as a senior healthcare investment banker at both Needham & Company and CRT Capital, where at the latter he was also involved in life sciences private equity investments. Earlier in his career, Adam was a portfolio management associate at AQR Capital and a healthcare investment banking analyst at Salomon Smith Barney. Mr. Mostafa graduated from Brown University with a degree in Economics.
Chris BittermanDirector, Hospital SalesDirector, Hospital Sales
Mr. Bitterman joined Cumberland in 2018 with a distinguished career in Acute Care and pharmaceutical sales management spanning over 25 years. Highlights include his roles as National Sales Director for Daiichi Sankyo and Regional Sales Director for Sanofi Aventis. Prior to Cumberland, Mr. Bitterman was employed at Lupin Pharmaceuticals as National Sales Director, leading the commercialization efforts for their Women’s Healthcare portfolio. As Cumberland’s Hospital Sales Director, he is responsible for leading our veteran Hospital Sales division, the development & execution of team business priorities, and delivering the financial objectives for our Hospital products. A native of Detroit, Michigan, Mr. Bitterman earned his bachelor’s and master’s degree in Business from Central Michigan University.
Kenny AcevedoDirector, Field SalesDirector, Field Sales
Prior to joining Cumberland 2011, Mr. Acevedo served in several roles including Hospital District Manager and Senior District Manager for Novartis Pharmaceuticals. Mr. Acevedo has been involved in the launching of several noteworthy pharmaceutical products. He also spent 5 years at ICN Pharmaceuticals as Regional Director for the West Coast. He is a graduate of New York State University at Stony Brook and he also received his Master’s in Health Administration from Long Island University.
John HammDirector, Corporate DevelopmentDirector, Corporate Development
In his role as Director of Corporate Development, Mr. Hamm is responsible for our alliances and relationships with domestic and international partners. Prior to joining Cumberland, Mr. Hamm began his career as Vice President, Controller at Viacom. He served as Vice President Finance, Chief Financial Officer and Chief Operations Officer in healthcare, broadcasting and the mobile cellular/wireless industries. His background includes senior-level positions with HealthSpring, Emdeon Business Services, CBS Television, MTV Networks, and Connected Nation. John holds both a bachelor's and a master’s degree in business administration with an emphasis in accounting.